Intravenous (IV) Hydration Therapy Market Report 2026

The intravenous (iv) hydration therapy market size has grown strongly in recent years. It will grow from $3.04 billion in 2025 to $3.32 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to clinical use of iv fluids for dehydration management, increasing hospitalization rates requiring fluid therapy, growing adoption of iv administration for rapid nutrient delivery, expansion of infusion-based treatments in hospitals, rising awareness of electrolyte imbalance management.

The intravenous (iv) hydration therapy market size is expected to see strong growth in the next few years. It will grow to $4.85 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to growth of wellness and preventive healthcare services, increasing popularity of home healthcare solutions, rising demand for quick recovery and energy boosting therapies, expansion of concierge and mobile iv therapy services, growing consumer focus on hydration and nutrient optimization. Major trends in the forecast period include rapid expansion of wellness and lifestyle iv therapy services, increasing consumer preference for preventive and recovery care, growing adoption of mobile and at-home iv hydration services, rising demand for customized iv infusion formulations, expansion of iv therapy beyond clinical settings.

The increasing prevalence of chronic diseases is expected to drive the growth of the intravenous (IV) hydration therapy market in the coming years. Chronic diseases are long-term health conditions, generally lasting for three months or more, and require ongoing management. The rising prevalence of chronic diseases is partly attributed to aging populations, as longer life expectancy increases the likelihood of developing conditions such as diabetes, heart disease, and arthritis. Intravenous (IV) hydration therapy aids in managing chronic diseases by rapidly restoring fluid and electrolyte balance, enhancing nutrient delivery, reducing fatigue, and improving overall cellular function, thereby enabling patients to better tolerate treatments and maintain daily health. For example, in April 2025, the Centers for Disease Control and Prevention, a US-based federal public health agency, reported that 76.4% of US adults, approximately 194 million people, had one or more chronic conditions in 2023, with prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93% among older adults. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the intravenous (IV) hydration therapy market.

Major companies in the intravenous (IV) hydration therapy market are concentrating on developing sterile solutions, such as CBD isolate, to meet the rising demand for CBD infusion and secure a competitive advantage in the market. CBD isolate is the purest form of cannabidiol, containing no other cannabinoids or plant compounds. For example, in September 2023, Apex Labs CBD, a US-based company offering a wide range of high-quality CBD products, launched Pico IV, a CBD isolate formulated for intravenous (IV) therapy. Pico IV's sterile solution enables safe intravenous administration, catering to the demand for CBD infusion in the rapidly expanding IV hydration therapy market. By reducing the CBD molecule to a picometer scale, Pico IV ensures maximum absorption and is exclusively available to licensed IV therapy providers for online purchase.

In September 2025, Next Health Management Group LLC (Next Health), a US-based provider of health-optimization, longevity, and wellness clinic services, acquired Lindora Franchise, LLC for an undisclosed amount. Through this acquisition, Next Health gains access to Lindora’s established network of medically supervised wellness clinics offering IV hydration therapy, metabolic-health solutions, hormone replacement therapies, and weight-management programs, thereby strengthening its IV hydration therapy capabilities while expanding its service offerings, clinic footprint, and operational scale across the wellness sector. Lindora is a US-based provider of metabolic-health and wellness clinics, recognized for its integrated approach combining IV hydration therapy, vitamin infusions, weight-loss treatments, and clinically guided wellness programs.

Major companies operating in the intravenous (iv) hydration therapy market are Revitalist, JW Life Science Corporation, Pfizer Inc., Fresenius Kabi AG, Medtronic Plc., Drip Hydration, Amanta Healthcare Ltd., Becton Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Sippex IV bag, REVIV, Braun Melsungen AG, The IV Doc Inc., Terumo Medical Corporation, Grifols S.A., Core IV Therapy LLC, Hospira, Teleflex Incorporated, Sichuan Kelun Pharmaceutical Co.Ltd., ICU Medical Inc., Vygon SAS.

North America was the largest region in the intravenous (IV) hydration therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) hydration therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intravenous (iv) hydration therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the intravenous hydration therapy market by increasing costs of imported iv bags, tubing sets, infusion pumps, and pharmaceutical-grade vitamins and minerals. These effects are most visible in wellness centers, home healthcare providers, and premium iv therapy services, particularly in north america and europe where global sourcing is common. Higher tariffs have increased operational costs and service pricing. However, tariffs are also driving local sourcing of consumables, domestic compounding, and innovation in cost-efficient iv delivery solutions, supporting long-term market stability.

The intravenous (iv) hydration therapy market research report is one of a series of new reports that provides intravenous (iv) hydration therapy market statistics, including intravenous (iv) hydration therapy industry global market size, regional shares, competitors with a intravenous (iv) hydration therapy market share, detailed intravenous (iv) hydration therapy market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous (iv) hydration therapy industry. This intravenous (iv) hydration therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Intravenous (IV) hydration therapy is a simple procedure that involves inserting a small IV into the arm to deliver fluids directly into the bloodstream. It supports treatment by enabling the body to absorb nutrients, blood, water, and medications more efficiently through the circulatory system.

The primary service types of intravenous (IV) hydration therapy include immune boosters, energy boosters, skin care, migraine, and others. Immunity boosters are products that claim to enhance the immune system and lower the risk of infections. The various components include medicated and non-medicated options, which are utilized by different end-users such as hospitals and clinics, wellness centers and spas, home healthcare, and others.

The intravenous (IV) hydration therapy market includes revenues earned by entities by providing normal saline, half-normal saline, lactated ringers, dextrose, and related detoxification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.